
    
      This is a prospective, stratified, randomized, controlled, comparative, parallel group,
      multi-center clinical trial comparing the proportion of ulcers completely healed by use of
      dehydrated human amnion/chorion membrane (dHACM) placed weekly versus placement of
      bioengineered skin substitute (BSS) placed weekly, versus standard of care in diabetic
      patients with a diabetic foot ulcer who have adequate arterial perfusion as defined in
      section, 2.0 (Patient Eligibility), for wound healing to the affected limb.
    
  